Juxtapid
NDC Package 76431-130-01

11-digit billing NDC: 76431013001 · Billing unit: EA · 28 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Juxtapid is contraindicated in the following conditions:Pregnancy [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1)].Concomitant administration of JUXTAPID with moderate or strong CYP3A4 inhibitors, as this can increase JUXTAPID exposure [see Warnings and Precautions (5.6), Drug Interactions (7.1), and Clinical Pharmacology (12.3)].Patients with moderate or severe hepatic impairment (based on Child-Pugh category B or C) and patients with active liver disease, including unexplained persistent elevations of serum transaminases [see Warnings and Precautions (5.1) and Use in Specific Populations (8.7)]. Marketed by Amryt Pharmaceuticals Dac, this product is identified by NDC 76431-130 and is authorized under FDA application NDA203858.

Identification & Billing

NDC Package Code
76431-130-01
Package Description
28 CAPSULE in 1 BOTTLE
Product Code
11-Digit Billing Format
76431013001
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
28 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Juxtapid
Dosage Form
-
Usage Information
JUXTAPID is contraindicated in the following conditions:Pregnancy [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1)].Concomitant administration of JUXTAPID with moderate or strong CYP3A4 inhibitors, as this can increase JUXTAPID exposure [see Warnings and Precautions (5.6), Drug Interactions (7.1), and Clinical Pharmacology (12.3)].Patients with moderate or severe hepatic impairment (based on Child-Pugh category B or C) and patients with active liver disease, including unexplained persistent elevations of serum transaminases [see Warnings and Precautions (5.1) and Use in Specific Populations (8.7)].

Regulatory & Marketing

Labeler Name
Amryt Pharmaceuticals Dac
FDA Application #
NDA203858
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-03-2013
End Marketing Date
07-29-2025
Listing Expiration
07-29-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76431-130-01 identifies a specific commercial package of 28 capsule in 1 bottle of Juxtapid, labeled by Amryt Pharmaceuticals Dac. This product is billed for "EA" each discreet unit and contains an estimated amount of 28 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amryt Pharmaceuticals Dac on January 03, 2013. The current certification is valid through July 29, 2025.

How is this Amryt Pharmaceuticals Dac product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76431013001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 28 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76431-130-01
11-Digit CMS (5-4-2)
76431-0130-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.